Metraipolis › archive › dc_a5b645449503
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41595737
- DOI
- 10.3390/biomedicines14010203
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T17:46:27.489Z
- SHA-256 of the archived text
fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c- Stable URL of this page
https://metraipolis.com/documento/dc_a5b645449503
How to cite
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737 — Europe PMC (en), https://europepmc.org/article/MED/41595737 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5b645449503 (Metraipolis archive dc_a5b645449503, sha256 fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c)
BibTeX
@misc{dca5b645449503,
title = {Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41595737},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5b645449503; sha256 fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595737. Agents can read the archived copy with the MCP tool read_document.